欧洲心胸外科学会机械循环支持患者欧洲登记处:第三份报告
该报告基于EUROMACS登记处2011年1月至2020年6月成人机械循环支持数据,按植入年代(2011-2013、2014-2017、2018-2020)分层,分析结局与不良事件率。共纳入72家医院4486例患者的4834例次操作,中位随访1.1年。结果显示Interagency Registry for Mechanically Assisted Circulatory Support分级和院内死亡随年代显著下降,5年死亡率55%、移植25%、脱离概率2%,主要感染多发生于植入早期,胆红素和肌酐仅在早期为死亡风险因素。
要点
- 共纳入4486例患者4834例次操作,中位随访1.1(四分位距0.3-2.6)年。
- Interagency Registry for Mechanically Assisted Circulatory Support 4-7级占比随年代下降(23%、25%、33%,P<0.001)。
- 院内死亡随年代显著下降(18.5%、17.2%、11.2%,P<0.001)。
核心结论
- EUROMACS成立10年来已成为基准比对和结局监测的参考。
- 患者特征和结局在植入年代间发生变化。
- 结局发生率和风险因素权重均具有时间依赖性。
研究设计与样本
- 欧洲心胸外科学会机械循环支持患者欧洲登记处(EUROMACS)第三份报告,纳入2011年1月至2020年6月成人患者操作。
- 排除随访完成率<60%的中心。
- 共纳入72家医院4486例患者的4834例次操作,中位随访1.1(四分位距0.3-2.6)年。
- 按植入年代分为2011-2013、2014-2017和2018-2020三个时期,计算不良事件率并分为早期(<3个月)和晚期(>3个月)。
- 采用单变量Cox回归及逐步时变风险比(<3个月 vs >3个月)探索死亡风险因素。
主要发现
- 年植入量(范围346-600例)无显著变化(P=0.41)。
- Interagency Registry for Mechanically Assisted Circulatory Support 4-7级占比在三个年代分别为23%、25%和33%(P<0.001)。
- 院内死亡在三个年代分别为18.5%、17.2%和11.2%(P<0.001)。
- 植入后5年总死亡率55%、移植率25%、脱离概率2%。
- 主要感染多发生于植入早期(不良事件率<3个月:1.44 vs >3个月:0.45)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In the third report of the European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery, outcomes of patients receiving mechanical circulatory support are reviewed in relation to implant era. METHODS: Procedures in adult patients (January 2011-June 2020) were included. Patients from centres with <60% follow-ups completed were excluded. Outcomes were stratified into 3 eras (2011-2013, 2014-2017 and 2018-2020). Adverse event rates (AERs) were calculated and stratified into early phase (<3 months) and late phase (>3 months). Risk factors for death were explored using univariable Cox regression with a stepwise time-varying hazard ratio (<3 vs >3 months). RESULTS: In total, 4834 procedures in 4486 individual patients (72 hospitals) were included, with a median follow-up of 1.1 (interquartile range: 0.3-2.6) years. The annual number of implants (range: 346-600) did not significantly change (P = 0.41). Both Interagency Registry for Mechanically Assisted Circulatory Support class (classes 4-7: 23, 25 and 33%; P < 0.001) and in-hospital deaths (18.5, 17.2 and 11.2; P < 0.001) decreased significantly between eras. Overall, mortality, transplants and the probability of weaning were 55, 25 and 2% at 5 years after the implant, respectively. Major infections were mainly noted early after the implant occurred (AER<3 months: 1.44 vs AER>3 months: 0.45). Bilirubin and creatinine levels were significant risk factors in the early phase but not in the late phase after the implant. CONCLUSIONS: In its 10 years of existence, EUROMACS has become a point of reference enabling benchmarking and outcome monitoring. Patient characteristics and outcomes changed between implant eras. In addition, both occurrence of outcomes and risk factor weights are time dependent.
引用
- de By TMMH, Schoenrath F, Veen KM, et al. The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report. Eur J Cardiothorac Surg. 2022. PMID: 35150247. doi:10.1093/ejcts/ezac032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。